NCT04696380

Brief Summary

The FDA has concluded that flavors (e.g. menthol) are associated with greater addiction potential in tobacco cigarettes (Gottlieb March 13, 2019). Whether the same is true for e-cigarettes and non-menthol flavors is unclear and our study should help answer this question. Our major hypothesis is that the pharmacological effect of nicotine to induce addiction will be greater with use of a preferred e-cigarette flavor than with use of a non-preferred flavor. The pharmacological effect will be measured by how much a larger nicotine dose increases addiction potential compared to a smaller dose.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Mar 2021

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

6 months

First QC Date

November 23, 2020

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Liking and wanting nicotine

    Average of "I feel good e-cigarette effects", "I want more of that e-cigarette I received", "I feel the e-cigarette strength" and "I like the e-cigarette effect" on a 0-100mm scale from "not at all" (0) to "extremely" (100).

    2 weeks

  • E-cigarette purchase task

    This is a modification of the Cigarette Purchase Task that asks how much users would spend to obtain their usual amount of e-liquids to use.

    2 weeks

  • E-cigarette and tobacco cigarette craving

    Modified items from the Mood and Physical Symptoms Scale that asks about change/strength of urges for e-cigarettes and tobacco cigarettes (0-4 scale, 0= not at all and 4= extremely) and strength of urges (1-5 scale, 1=slight and 5= extremely strong).

    2 weeks

  • Modified Drug Effect Questionnaire

    Modified version of the Drug Effects Questionnaire where participants rate acute responses to the e-cigarette drug effects on a 0-100 mm scale, from "not at all" (0) to "extremely" (100).

    2 weeks

  • Modified Labeled Hedonic Scale

    1 item about like/dislike of the e-cigarette taste using a modified version of the Labeled Hedonic Scale, a category ratio scale that ranges from -100 (most disliked) to 100 (most liked).

    2 weeks

  • Modified Labeled Magnitude Scale

    1 item about e-cigarette taste intensity using a modified version of the Labeled Magnitude Scale, which is a category ratio scale with 7 semantic labels: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "strongest imaginable", with responses coded on a 0-100 scale (0= no sensation, 100= strongest imaginable).

    2 weeks

Study Arms (4)

High nicotine, preferred flavor

EXPERIMENTAL

Participants will sample their preferred flavored JUUL e-cigarette at 5% nicotine strength.

Drug: NicotineDevice: JUUL e-cigarette

High nicotine, non-preferred flavor

EXPERIMENTAL

Participants will sample their non-preferred flavored JUUL e-cigarette at 5% nicotine strength.

Drug: NicotineDevice: JUUL e-cigarette

Low nicotine, preferred flavor

EXPERIMENTAL

Participants will sample their preferred flavored JUUL e-cigarette at 3% nicotine strength.

Drug: NicotineDevice: JUUL e-cigarette

Low nicotine, non-preferred flavor

EXPERIMENTAL

Participants will sample their non-preferred flavored JUUL e-cigarette at 3% nicotine strength.

Drug: NicotineDevice: JUUL e-cigarette

Interventions

Participants will sample high vs low nicotine.

High nicotine, non-preferred flavorHigh nicotine, preferred flavorLow nicotine, non-preferred flavorLow nicotine, preferred flavor

Participants will sample preferred vs non-preferred JUUL flavors.

High nicotine, non-preferred flavorHigh nicotine, preferred flavorLow nicotine, non-preferred flavorLow nicotine, preferred flavor

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • comfortable reading and writing English
  • own a JUUL brand e-cigarette they have used at least 10 times in the past 30 days
  • use JUUL e-cigarettes and JUUL pods with 5% nicotine
  • used e-cigarettes on 4+ days a week in the last 30 days
  • use or do not use tobacco cigarettes
  • do not plan to quit e-cigarettes in the next 30 days
  • non-pregnant females verified by pregnancy test
  • access to the internet in a location where they could join a videoconference call and legally use their JUUL.
  • Reside in VT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vermont

Burlington, Vermont, 05401, United States

Location

Related Publications (1)

  • Peasley-Miklus C, Klemperer EM, Hughes JR, Villanti AC, Krishnan-Sarin S, DeSarno MJ, Mosca LA, Su A, Cassidy RN, Feinstein MJP. The interactive effects of JUUL flavor and nicotine concentration on addiction potential. Exp Clin Psychopharmacol. 2023 Apr;31(2):336-342. doi: 10.1037/pha0000591. Epub 2022 Sep 1.

MeSH Terms

Conditions

Tobacco Use Disorder

Interventions

Nicotine

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Solanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Study Officials

  • John R Hughes, MD

    University of Vermont

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 23, 2020

First Posted

January 6, 2021

Study Start

March 1, 2021

Primary Completion

August 31, 2021

Study Completion

August 31, 2021

Last Updated

March 22, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations